دورية أكاديمية
أعرض في EDS

Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors.

التفاصيل البيبلوغرافية
العنوان: Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors.
المؤلفون: Ognjenovic NB; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA., Bagheri M; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA., Mohamed GA; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA., Xu K; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA., Chen Y; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA., Mohamed Saleem MA; Lifebytes India Pvt Ltd, Bengaluru, India., Brown MS; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA., Nagaraj SH; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia; Translational Research Institute, Brisbane, QLD 4102, Australia., Muller KE; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA; Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA., Gerber SA; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA., Christensen BC; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA., Pattabiraman DR; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. Electronic address: raman@dartmouth.edu.
المصدر: Developmental cell [Dev Cell] 2020 Dec 07; Vol. 55 (5), pp. 544-557.e6. Date of Electronic Publication: 2020 Oct 28.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101120028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1551 (Electronic) Linking ISSN: 15345807 NLM ISO Abbreviation: Dev Cell Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Cambridge, Mass. : Cell Press, c2001-
مواضيع طبية MeSH: Cell Differentiation* , Cell Self Renewal*, Cyclic AMP-Dependent Protein Kinases/*metabolism , Mammary Neoplasms, Animal/*enzymology , Mammary Neoplasms, Animal/*pathology, Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Lineage ; Disease Models, Animal ; Disease Progression ; Enzyme Activation ; Female ; Gene Amplification ; Genetic Loci ; Genome, Human ; Humans ; Mammary Neoplasms, Animal/genetics ; Mice ; Neoplasm Metastasis ; SOXC Transcription Factors/metabolism ; Signal Transduction
مستخلص: Differentiation therapy utilizes our understanding of the hierarchy of cellular systems to pharmacologically induce a shift toward terminal commitment. While this approach has been a paradigm in treating certain hematological malignancies, efforts to translate this success to solid tumors have met with limited success. Mammary-specific activation of PKA in mouse models leads to aberrant differentiation and diminished self-renewing potential of the basal compartment, which harbors mammary repopulating cells. PKA activation results in tumors that are more benign, exhibiting reduced metastatic propensity, loss of tumor-initiating potential, and increased sensitivity to chemotherapy. Analysis of tumor histopathology revealed features of overt differentiation with papillary characteristics. Longitudinal single-cell profiling at the hyperplasia and tumor stages uncovered an altered path of tumor evolution whereby PKA curtails the emergence of aggressive subpopulations. Acting through the repression of SOX4, PKA activation promotes tumor differentiation and represents a possible adjuvant to chemotherapy for certain breast cancers.
Competing Interests: Declaration of Interests The lead author has a patent titled “Methods and Compositions for Targeting Cancer Stem Cells.” U.S. Patent no. 10,398,672 (issued September 3, 2019) for the activation of PKA as a means of targeting breast cancer stem cells.
(Copyright © 2020 Elsevier Inc. All rights reserved.)
References: Methods Mol Biol. 2013;946:395-409. (PMID: 23179846)
Cell. 2011 Mar 4;144(5):646-74. (PMID: 21376230)
Front Biosci. 2000 Aug 01;5:D678-93. (PMID: 10922298)
Science. 2014 Oct 3;346(6205):1248012. (PMID: 25278615)
Nature. 2011 Oct 09;479(7372):189-93. (PMID: 21983963)
Cancer Cell. 2013 Jun 10;23(6):768-83. (PMID: 23764001)
Nature. 2014 Sep 4;513(7516):110-4. (PMID: 25043045)
Science. 2016 Mar 4;351(6277):aad3680. (PMID: 26941323)
Nature. 2012 Apr 18;486(7403):346-52. (PMID: 22522925)
Nucleic Acids Res. 2005 Mar 22;33(5):e51. (PMID: 15784609)
Oncol Rep. 2011 Feb;25(2):559-65. (PMID: 21165564)
Nat Rev Mol Cell Biol. 2013 Jul;14(7):416-29. (PMID: 23719536)
Bioinformatics. 2014 Apr 1;30(7):923-30. (PMID: 24227677)
Sci Signal. 2011 Jun 28;4(179):rs5. (PMID: 21712546)
Methods Mol Biol. 2010;604:55-71. (PMID: 20013364)
Mol Cell Biochem. 2014 Jan;386(1-2):63-71. (PMID: 24096736)
Cell. 2009 Aug 21;138(4):645-659. (PMID: 19682730)
Physiol Rev. 2004 Jan;84(1):137-67. (PMID: 14715913)
Sci Rep. 2018 Sep 26;8(1):14373. (PMID: 30258192)
Nat Commun. 2016 May 10;7:11479. (PMID: 27161491)
Cancer Res. 2008 Apr 15;68(8):2671-7. (PMID: 18413734)
Cell. 2013 Dec 19;155(7):1639-51. (PMID: 24332913)
N Engl J Med. 1993 Jul 15;329(3):177-89. (PMID: 8515790)
Cell Signal. 2012 Dec;24(12):2396-406. (PMID: 22954688)
Breast Cancer Res Treat. 2010 Aug;122(3):637-45. (PMID: 20524058)
Cancer Cell. 2020 Jul 13;38(1):129-143.e7. (PMID: 32531271)
Genome Med. 2015 Feb 02;7(1):20. (PMID: 25722745)
EMBO J. 1993 Oct;12(10):3847-54. (PMID: 8404853)
Nat Methods. 2017 Mar;14(3):309-315. (PMID: 28114287)
Nature. 2012 Oct 4;490(7418):61-70. (PMID: 23000897)
Transgenic Res. 2001 Dec;10(6):545-53. (PMID: 11817542)
Mol Biol Cell. 2010 Jan 15;21(2):244-53. (PMID: 19923321)
Nat Cell Biol. 2015 Jun;17(6):793-803. (PMID: 25961504)
Nat Methods. 2017 Oct;14(10):979-982. (PMID: 28825705)
Nature. 2000 Aug 17;406(6797):747-52. (PMID: 10963602)
Cancer Res. 2017 Aug 1;77(15):3982-3989. (PMID: 28428275)
Mol Cell Biol. 2007 Nov;27(22):7802-15. (PMID: 17875931)
DNA Cell Biol. 2019 Oct;38(10):1125-1133. (PMID: 31408364)
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11236-40. (PMID: 7972041)
Genome Biol. 2014 Feb 03;15(2):R30. (PMID: 24490765)
Genesis. 2007 Sep;45(9):593-605. (PMID: 17868096)
Blood. 1988 Aug;72(2):567-72. (PMID: 3165295)
Nat Biotechnol. 2018 Jun;36(5):411-420. (PMID: 29608179)
Genesis. 2005 Nov;43(3):109-19. (PMID: 16155866)
Nat Commun. 2016 Sep 14;7:12751. (PMID: 27624192)
Nat Genet. 2020 Aug;52(8):790-799. (PMID: 32690948)
Am J Pathol. 2003 Nov;163(5):2113-26. (PMID: 14578209)
Dev Cell. 2014 Jan 27;28(2):147-60. (PMID: 24412575)
Science. 2017 Jul 21;357(6348):. (PMID: 28729483)
J Clin Invest. 2013 Mar;123(3):1348-58. (PMID: 23391723)
Nature. 2018 Apr;556(7702):463-468. (PMID: 29670281)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Cell Rep. 2015 Sep 29;12(12):2035-48. (PMID: 26365194)
Nat Biotechnol. 2014 Apr;32(4):381-386. (PMID: 24658644)
Sci Transl Med. 2011 Jul 20;3(92):92ra66. (PMID: 21775669)
Cancer Cell. 2020 Aug 10;38(2):212-228.e13. (PMID: 32707078)
Nature. 2016 Jan 7;529(7584):97-100. (PMID: 26700806)
Proteomics. 2013 Jan;13(1):22-4. (PMID: 23148064)
Genome Res. 2017 Mar;27(3):491-499. (PMID: 28100584)
Mol Syst Biol. 2014 Oct 30;10:757. (PMID: 25358341)
Nat Cell Biol. 2018 Jul;20(7):811-822. (PMID: 29941929)
Nucleic Acids Res. 2008 May;36(9):3101-17. (PMID: 18403418)
Cell Death Dis. 2018 Feb 7;9(2):192. (PMID: 29416006)
Mol Cell Biol. 1992 Mar;12(3):954-61. (PMID: 1312220)
Oncogene. 2015 Feb 26;34(9):1160-73. (PMID: 24662820)
Nat Med. 2014 Sep;20(9):1035-42. (PMID: 25150496)
Trends Cell Biol. 2002 Jun;12(6):258-66. (PMID: 12074885)
Cell. 2012 Mar 2;148(5):1015-28. (PMID: 22385965)
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63. (PMID: 26831077)
Nature. 2015 Sep 10;525(7568):256-60. (PMID: 26331542)
Nat Protoc. 2019 Jan;14(1):68-85. (PMID: 30464214)
معلومات مُعتمدة: P30 CA023108 United States CA NCI NIH HHS; R00 CA201574 United States CA NCI NIH HHS; R01 CA216265 United States CA NCI NIH HHS; R01 GM122846 United States GM NIGMS NIH HHS
فهرسة مساهمة: Keywords: epithelial-mesenchymal transition; mammary development; tumor differentiation; tumor evolution; tumor metastasis
المشرفين على المادة: 0 (SOX4 protein, human)
0 (SOXC Transcription Factors)
EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)
تواريخ الأحداث: Date Created: 20201029 Date Completed: 20210311 Latest Revision: 20211208
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC7726035
DOI: 10.1016/j.devcel.2020.10.004
PMID: 33120014
قاعدة البيانات: MEDLINE
الوصف
تدمد:1878-1551
DOI:10.1016/j.devcel.2020.10.004